NYU Langone Hospital - Long Island | Dialysis and Nephrology

Research site

(Unclaimed)

Location

200 Old Country Road, Mineola, New York, United States of America

Site insights

Top conditions

Top treatments

Cisplatin

Cyclophosphamide

Carboplatin

Vincristine Sulfate

Etoposide

Nivolumab

Lenalidomide

Doxorubicin Hydrochloride

Prednisone

Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

13 of 119 total trials

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation (Krascendo 170)

The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and activity of divarasib combined with other anti-cancer therapies in pa...

Enrolling

Non-Small Cell Lung Cancer

Drug: Pembrolizumab

Drug: Carboplatin

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

This study is designed to evaluate the safety and efficacy of ifinatamab deruxtecan (I-DXd) in combination with immune checkpoint inhibitor (ICI) ate...

Enrolling

Extensive Stage-small Cell Lung Cancer

Drug: Carboplatin

Drug: Ifinatamab deruxtecan

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

The purpose of this study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from ba...

Active, not recruiting

Severe Hypertriglyceridemia

Drug: Placebo

Drug: Olezarsen

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic k...

Enrolling

Overweight or Obesity

CKD

Drug: Placebo

Drug: Retatrutide

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Enrolling

Sjögren's Syndrome

Other: Placebo

Drug: Deucravacitinib

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor D...

Enrolling

Stage III Colon Cancer

Drug: mFOLFOX6 3-6 month

Device: Signatera test

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation...

Enrolling

Degenerative Mitral Valve Disease

Functional Mitral Regurgitation

Device: Edwards PASCAL System

Device: Abbott Mitraclip System

PF-07104091 as a Single Agent and in Combination Therapy

To assess the safety and tolerability of increasing doses of PF-07104091 and to estimate the Maximum Tolerated Dose (MTD) and/or select the Recommend...

Active, not recruiting

Breast Cancer

Small Cell Lung Cancer

Drug: PF-07104091 monotherapy dose expansion (ovarian)

Drug: PF-07104091 + palbociclib + fulvestrant

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Hea...

Enrolling

Aortic Valve Stenosis

Aortic Stenosis, Calcific

Device: SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA

RADIANCE Continued Access Protocol (RADIANCE CAP)

RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to...

Active, not recruiting

Hypertension

Hypertension, Resistant to Conventional Therapy

Device: Renal Denervation

Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

This study is to understand if the study vaccine (called VLA15) is safe in healthy children.We are looking for children who:* are healthy* are age 5...

Active, not recruiting

Lyme Disease

Other: Normal Saline

Biological: VLA15

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in pa...

Enrolling

Prognostic Stage IA Breast Cancer AJCC v8

Prognostic Stage IB Breast Cancer AJCC v8

Biological: Trastuzumab Emtansine

Other: Quality-of-Life Assessment